In hepatocytes, methotrexate (MTX) is converted to MTX-polyglutamate (MTX-PGs) by folylpolyglutamate synthase (FPGS) leading to apoptosis, fibrosis, oxidative stress, inflammation, and steatosis. This evidence concerns the gene FPGS and steatosis.